enGene Therapeutics Inc. (ENGN) stock
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$2.41+0.13 (+5.70%)
Close on Nov 13, 2026Market cap $161.51MP/E –Yield 0.00%
enGene Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for enGene Therapeutics
enGene Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?